Pregled bibliografske jedinice broj: 464677
Influence of nadroparin decreasing on blood pressure in haemodialysed patients
Influence of nadroparin decreasing on blood pressure in haemodialysed patients // Journal of Hypertension
Oslo, Norveška, 2010. (poster, nije recenziran, sažetak, znanstveni)
CROSBI ID: 464677 Za ispravke kontaktirajte CROSBI podršku putem web obrasca
Naslov
Influence of nadroparin decreasing on blood pressure in haemodialysed patients
Autori
Šain, Milenka ; Ljutić, Dragan ; Kovačić, Vedran ; Radić, Josipa ; Jeličić, Ivo.
Vrsta, podvrsta i kategorija rada
Sažeci sa skupova, sažetak, znanstveni
Izvornik
Journal of Hypertension
/ - , 2010
Skup
20th Annual Meeting of the European Society of Hypertension
Mjesto i datum
Oslo, Norveška, 18.06.2010. - 21.06.2010
Vrsta sudjelovanja
Poster
Vrsta recenzije
Nije recenziran
Ključne riječi
Hemodialysis; nadroparin; blood pressure
Sažetak
INTRODUCTION: Patients receiving chronic haemodialysis (HD), especially diabetics, have an increased risk of arterial hypertension and cardiovascular morbidity. Previous studies were described hypotensive effect of systemic heparin administration. The aim of this study was to assess the impact of decreasing single bolus dose of low molecular weight heparin (LMWH) nadroparin on blood pressure among patients on HD. DESIGN AND METHOD: Forty patients (18 females), 20 diabetics, mean age 64, 93±12, 34 years (range 36-84) undergoing intermittent HD for 62, 63±53, 97 months (range 5-196) were included in this 12-weeks long prospective study. The recommended nadroparin bolus dose was decreased by 25% after 4 weeks, again by 25% after 8 weeks, and maintained 50% lower doses for 4 weeks. The blood pressure was measured at the beginning of each HD. The efficacy and safety of LMWH were assessed by dialysis system clotting and the dose of LMWH was respectively changed. RESULTS: Overall, there was difference between the first and the last LMWH dose but not between the first and the last predialysis blood pressure parameters (Table 1.). In the subgroup of diabetics the differences in the first and the last predialysis systolic and PP were found (Table 2.). CONCLUSION: This trial demonstrated the influence of lowering nadroparin doses on blood pressure in HD patients. The significant decreasing of LMWH level led to paradoxally decreasing in systolic and pulse pressure only in diabetics on chronic haemodialysis.
Izvorni jezik
Engleski
Znanstvena područja
Kliničke medicinske znanosti
POVEZANOST RADA
Projekti:
216-0000000-0520 - Imunološke, hematološke, reološke i druge osobitosti uremijskog sindroma (Ljutić, Dragan, MZOS ) ( CroRIS)
Ustanove:
Medicinski fakultet, Split
Profili:
Vedran Kovačić
(autor)
Dragan Ljutić
(autor)
Milenka Šain
(autor)
Ivo Jeličić
(autor)
Josipa Radić
(autor)
Citiraj ovu publikaciju:
Časopis indeksira:
- Current Contents Connect (CCC)
- Web of Science Core Collection (WoSCC)
- Science Citation Index Expanded (SCI-EXP)
- SCI-EXP, SSCI i/ili A&HCI
- Scopus
- MEDLINE